Intrinsic Value of S&P & Nasdaq Contact Us

Myomo, Inc. MYO AMEX

American Stock Excha • Healthcare • Medical - Devices • US • USD

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.10
+40.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Myomo, Inc. (MYO) has a negative trailing P/E of -1.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 4.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -54.88%, forward earnings yield 20.45%. PEG 0.04 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (97/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.04); analyst target implies upside (+40.6%).
  • Forward P/E 4.9 — analysts expect a return to profitability with estimated EPS of $0.16 for FY2029.
  • PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -54.88% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 20.45% as earnings recover.
  • Analyst consensus target $1.10 (+40.6% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 54/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
54/100
SG Score
View full scorecard →
VALUE
97/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
46/100
→ Income
GROWTH
100/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — MYO

Valuation Multiples
P/E (TTM)-1.8
Forward P/E4.9
PEG Ratio0.04
Forward PEG0.04
P/B Ratio2.49
P/S Ratio0.64
EV/EBITDA-2.5
Per Share Data
EPS (TTM)$-0.37
Forward EPS (Est.)$0.16
Book Value / Share$0.27
Revenue / Share$0.98
FCF / Share$-0.43
Yields & Fair Value
Earnings Yield-54.88%
Forward Earnings Yield20.45%
Dividend Yield0.00%
Analyst Target$1.10 (+40.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -393.4 3.95 -81.18 1,289.83 -
2017 -1.3 0.00 1.30 10.39 -
2018 -1.7 0.02 2.75 7.24 -
2019 -0.5 0.02 2.74 1.30 -
2020 -1.9 0.02 1.94 2.96 -
2021 -3.8 0.08 2.59 2.88 -
2022 -0.3 0.02 0.57 0.23 -
2023 -17.9 0.22 16.22 7.58 -
2024 -39.3 0.92 9.84 7.47 -
2025 -2.4 -0.02 3.34 0.93 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.56 $1.1M $-3.62M -327.8%
2017 $-84.05 $1.56M $-12.1M -776%
2018 $-25.15 $2.44M $-10.32M -422.1%
2019 $-19.20 $3.84M $-10.63M -277%
2020 $-3.62 $7.58M $-12.04M -158.8%
2021 $-1.78 $13.86M $-10.37M -74.9%
2022 $-1.52 $15.56M $-10.72M -68.9%
2023 $-0.28 $19.24M $-8.15M -42.3%
2024 $-0.16 $32.55M $0.00 0%
2025 $-0.37 $40.93M $-15.57M -38.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.34 $-0.35 – $-0.33 $44.21M $42.5M – $45.92M 3
2027 $-0.25 $-0.26 – $-0.23 $50.22M $44.64M – $55.79M 3
2028 $-0.05 $-0.06 – $-0.05 $69.51M $64.42M – $75.21M 1
2029 $0.16 $0.14 – $0.18 $84.65M $78.45M – $91.59M 1
2030 $0.35 $0.32 – $0.39 $99.56M $92.26M – $107.72M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message